{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:23Z","timestamp":1788872423160,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":2576,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Roche and Sanofi-Aventis"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1093\/annonc\/mds129","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T03:21:18Z","timestamp":1340767278000},"page":"2827-2834","source":"Crossref","is-referenced-by-count":61,"title":["Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)"],"prefix":"10.1016","volume":"23","author":[{"given":"P.C.","family":"Thuss-Patience","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Hofheinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Florsch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Daum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mantovani-L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bichev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Breithaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kneba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Glanemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Schlattmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Reichardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mds129_bb0010","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"24","author":"Kamangar","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds129_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds129_bb0020","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: A FNCLCC and FFCD multicenter phase III Trial","volume":"29","author":"Ychou","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds129_bb0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2007.11.001","article-title":"Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group","volume":"44","author":"Van Cutsem","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mds129_bb0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1093\/annonc\/mds129_bb0035","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1586\/era.11.172","article-title":"Capecitabine in gastric cancer","volume":"11","author":"Bang","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1093\/annonc\/mds129_bb0040","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group","volume":"24","author":"Van Cutsem","year":"2006","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1093\/annonc\/mds129_bb0045","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/annonc\/mdn403","article-title":"Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie","volume":"19","author":"Al-Batran","year":"2008","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1093\/annonc\/mds129_bb0050","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdm269","article-title":"Split-dose docetaxel, cisplatin and leucovorin\/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial","volume":"18","author":"Lorenzen","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mds129_bb0055","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2010.28.15_suppl.4014","article-title":"Random assignment multicenter phase II study of modified docetaxel, cisplatin, fluorouracil (mDCF) versus DCF with growth factor support (GCSF) in metastatic gastroesophageal adenocarcinoma (GE)","volume":"28","author":"Shah","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds129_bb0060","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1245\/s10434-009-0838-1","article-title":"Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer","volume":"17","author":"Sym","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds129_bb0065","series-title":"TNM Classification of Malignant Tumours","author":"Sobin","year":"2002"},{"issue":"3","key":"10.1093\/annonc\/mds129_bb0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1093\/annonc\/mds129_bb0075","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker","year":"2003","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds129_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"issue":"3","key":"10.1093\/annonc\/mds129_bb0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10120-003-0245-4","article-title":"Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study","volume":"6","author":"Ott","year":"2003","journal-title":"Gastric Cancer"},{"issue":"9","key":"10.1093\/annonc\/mds129_bb0090","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdl133","article-title":"A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer","volume":"17","author":"Brenner","year":"2006","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1093\/annonc\/mds129_bb0095","article-title":"Approximate is better than \u2018exact\u2019 for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Stat"},{"key":"10.1093\/annonc\/mds129_bb0100","series-title":"binom: Binomial Confidence Intervals For Several Parameterizations","author":"Sundar","year":"2009"},{"key":"10.1093\/annonc\/mds129_bb0105","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/sj.bjc.6602645","article-title":"Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial","volume":"92","author":"Lorenzen","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds129_bb0110","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdl005","article-title":"Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group","volume":"17","author":"Giordano","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mds129_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/bjc.2011.278","article-title":"Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts","volume":"105","author":"Thuss-Patience","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds129_bb0120","first-page":"868","article-title":"Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer","volume":"16","author":"Biffi","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1093\/annonc\/mds129_bb0125","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1093\/annonc\/mds129_bb0130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.coc.0000143877.53314.9c","article-title":"Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer","volume":"28","author":"Chun","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"10.1093\/annonc\/mds129_bb0135","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/sj.bjc.6601724","article-title":"A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer","volume":"90","author":"Park","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds129_bb0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000086773","article-title":"Phase II study of docetaxel and capecitabine in patients with metastatic or recurrent gastric cancer","volume":"68","author":"Kim","year":"2005","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mds129_bb0145","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/sj.bjc.6605070","article-title":"A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma","volume":"100","author":"Starling","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds129_bb0150","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ijc.26180","article-title":"Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel","volume":"130","author":"Homann","year":"2012","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1093\/annonc\/mds129_bb0155","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial","volume":"6","author":"Burmeister","year":"2005","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1093\/annonc\/mds129_bb0160","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1200\/JCO.2008.17.0506","article-title":"Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction","volume":"27","author":"Stahl","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1093\/annonc\/mds129_bb0165","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1093\/annonc\/mds129_bb0170","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1093\/annonc\/mds129_bb0175","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/sj.bjc.6605686","article-title":"Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy","volume":"102","author":"Fareed","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds129_bb0180","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1200\/jco.2010.28.15_suppl.4075","article-title":"Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: Safety and response results from a multicenter phase II trial","volume":"28","author":"Ferri","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419375210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419375210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/11\/2827\/13786760\/mds129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:46:26Z","timestamp":1637196386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419375210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0923753419375210"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds129","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717952476.793457947","asserted-by":"object"}]},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}